AEVA Aeva Technologies, Inc.
Price Chart
Executive Summary
Aeva Technologies filed a preliminary prospectus supplement for a $100 million common stock offering, with an underwriters' option for an additional $15 million. The offering is being led by Morgan Stanley, Goldman Sachs, and Oppenheimer. Proceeds are earmarked for general corporate purposes, including AI infrastructure and Co-Packaged Optics. The filing is a preliminary prospectus supplement (subject to completion), so final pricing and share count are not yet determined. This is a dilutive event for existing shareholders, as the company had a stockholders' deficit of $(12.4) million as of March 31, 2026.
Actionable Insight
Monitor the final pricing and share count in the final prospectus supplement. The $100M offering represents approximately 6.25% of the current market cap ($1.6B) and will be significantly dilutive given the negative book value. Watch for the underwriters' exercise of the greenshoe option. The stock may face near-term selling pressure as the market absorbs the new supply.
Key Facts
- Aeva is offering $100,000,000 of common stock in an underwritten public offering.
- Underwriters have a 30-day option to purchase an additional $15,000,000 of shares.
- Joint book-running managers are Morgan Stanley, Goldman Sachs & Co. LLC, and Oppenheimer & Co.
- Proceeds are intended for general corporate purposes, including AI infrastructure and Co-Packaged Optics (CPO).
- As of March 31, 2026, Aeva had $31.2 million in cash and cash equivalents and a stockholders' deficit of $(12.4) million.
- The company had $96.8 million in long-term debt as of March 31, 2026.
- The offering is being made under a shelf registration statement (S-3ASR) filed on June 3, 2026.
- The filing is a preliminary prospectus supplement; final pricing and share count are not yet determined.
Financial Impact
Dilutive offering of $100 million in common stock; exact share count and pricing TBD. The company had a negative tangible book value of $(0.21) per share as of March 31, 2026, indicating substantial dilution for new investors.
Risk Factors
- Immediate and substantial dilution to existing shareholders due to the offering and negative book value.
- Potential for further dilution from outstanding options, RSUs, warrants, and convertible notes.
- The company has a history of losses and limited sales, with an accumulated deficit of $(792.3) million.
- Proceeds are for general corporate purposes, providing no specific catalyst or ROI guarantee.
Market Snapshot
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 424B5 Filing (Primary) | 0001193125-26-256366 |
| Document: 0001193125-26-256366-index-headers.html | 0001193125-26-256366 |
| Document: 0001193125-26-256366-index.html | 0001193125-26-256366 |
| Document: 0001193125-26-256366.txt | 0001193125-26-256366 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 4, 2026
today
|
8-K
| $24.38 awaiting T+1 | awaiting T+1 | — | $22.69 (+6.91%) |
|
Jun 4, 2026
today
|
424B5
| $24.38 awaiting T+1 | awaiting T+1 | — | $22.69 (+6.91%) |
|
Jun 4, 2026
1d ago
|
424B5
| — | awaiting T+1 | — | — |
|
Jun 3, 2026
1d ago
|
S-3ASR
| $25.30 awaiting T+1 | awaiting T+1 | — | $22.69 (−10.28%) |
|
Jun 1, 2026
3d ago
|
8-K
| $27.76 $25.31 | ▼ −8.83% | ▼ −8.13% | $22.69 (−18.25%) |
|
May 5, 2026
4w ago
|
Insider Cluster
| $15.24 $16.57 | ▲ +8.73% | ▲ +7.34% | $22.69 (+48.92%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access